Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial
Alejandro Arenas‐Pinto(Aptiv (United States)), Simon Collins(Ghent University Hospital), Christine Katlama(Université Paris Cité), Cláudia Afonso(Hospital de Santa Maria), Julie Fox(National Health Service), Dalibor Sedláček(Charles University), William M Chasanov(Cooper University Hospital), Nathan W. Cummins(Mayo Clinic), Birgit Grund(University of Minnesota), Pim Brouwers(National Institutes of Health), Karin L. Klingman(National Institutes of Health), Shweta Sharma(University of Minnesota), Estebán Martínez(Instituto de Salud Carlos III), Eynat Kedem(Rambam Health Care Campus), Juan Sierra‐Madero(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Patricia M. Flynn(St. Jude Children's Research Hospital), David A. Cooper(Illinois Institute of Technology)
Cited by 25
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Antiretroviral Therapy in Adults
|JAMA|2000|1k